Diabetic Gastroparesis Clinical Trials 2023

Diabetic Gastroparesis Clinical Trials 2023

Diabetic Gastroparesis research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in diabetic gastroparesis clinical trials today.

Diabetic Gastroparesis Clinical Trials

Here are the 6 most popular medical studies for diabetic gastroparesis

Popular filter options for diabetic gastroparesis trials

GP Clinical Trials

View 29 GP medical studies.

Type 2 Diabetes Clinical Trials

View 29 Type 2 Diabetes medical studies.

Diabetic Gastroparesis Clinical Trials With No Placebo

View 29 diabetic gastroparesis medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to diabetic gastroparesis

What are the top hospitals conducting diabetic gastroparesis research?

When it comes to cutting-edge clinical trials for diabetic gastroparesis, several top hospitals are leading the charge. In Boston, Massachusetts General Hospital is at the forefront with three ongoing trials dedicated to this condition and an impressive history of 13 completed trials. With their first recorded trial dating back to 2005, they have been exploring innovative treatment options for over a decade. Meanwhile, in Cleveland, the renowned Cleveland Clinic Foundation has also made significant contributions with three active trials and four completed studies since their inaugural diabetic gastroparesis trial in 2022.

Johns Hopkins Bayview Medical Center in Baltimore has likewise emerged as a prominent player in this field. They currently have three ongoing clinical trials for diabetic gastroparesis and have conducted ten previous studies since initiating their first trial in 2012. Additionally adding itself to this list is the University of Michigan in Ann Arbor where two active clinical tests are being carried out alongside five previously held investigations; theirs can be traced back only eight years ago until2013.

Lastly but not least, Mayo Clinic located in Rochester boasts two current diabetic gastroparesis clinical trials along with an impressive track record of eight prior ones that began backin2010.The collective efforts of these esteemed institutions demonstrate unwavering commitment towards understanding and finding solutions for diabetic gastroparesis—a condition characterized by delayed stomach emptying due to diabetes-related nerve damage—which affects countless individuals globally.

These hospitals serve as beacons of hope for those living with diabetic gastroparesis while representing medical progressions that impact lives far beyond their respective locations

Which are the best cities for diabetic gastroparesis clinical trials?

When it comes to diabetic gastroparesis clinical trials, several cities have emerged as hubs of research and development. Houston, Texas; Boston, Massachusetts; Miami, Florida; Baltimore, Maryland; and Little Rock, Arkansas are all actively conducting studies in this field. Each city offers a varying number of active trials focused on different investigational treatments such as CIN-102 Dose 1, Domperidone, Cognitive Behavioral Therapy, Transcutaneous Electroacupuncture, and Tradipitant. These cities serve as crucial centers for individuals with diabetic gastroparesis seeking participation in cutting-edge clinical trials that could potentially lead to improved management strategies for this condition.

Which are the top treatments for diabetic gastroparesis being explored in clinical trials?

Clinical trials for diabetic gastroparesis are currently exploring several promising treatments. One such treatment is the Atmo Motility Gas Capsule System, which is being tested in one active trial and marks its first listing in 2023. Another innovative approach under investigation is endoscopic per-oral pyloromyotomy (POP), with one active trial and initial listing in 2022. Additionally, researchers are studying EndoFLIP, a technique that has shown potential through two past trials and continues to be explored in one ongoing trial since its introduction in 2015. These advancements hold promise for improving the lives of individuals living with diabetic gastroparesis by addressing the challenges posed by this condition's delayed gastric emptying.

What are the most recent clinical trials for diabetic gastroparesis?

Recent clinical trials offer hope and potential breakthroughs for individuals suffering from diabetic gastroparesis. CIN-102 Dose 1, a Phase 2 trial that became available on 3/27/2023, seeks to address the challenges of this condition. Additionally, tradipitant and nimacimab have shown promise as potential treatments in their respective Phase 3 and Phase 2 trials conducted in previous years. Rifaximin also holds potential based on its Phase 2 trial results from June 2019. These innovative studies highlight the ongoing efforts to improve the lives of those affected by diabetic gastroparesis through cutting-edge research.

What diabetic gastroparesis clinical trials were recently completed?

Recently completed clinical trials have advanced the understanding and treatment of diabetic gastroparesis, a condition characterized by delayed stomach emptying in individuals with diabetes. In March 2022, Processa Pharmaceuticals concluded their trial investigating PCS12852 as a potential therapy for this debilitating disorder. Additionally, Neurogastrx, Inc.'s NG101 trial was successfully completed in August 2020. These significant milestones signify important progress in addressing the challenges faced by patients with diabetic gastroparesis and offer hope for improved management strategies moving forward.